Figure 1.
Purification of lEVs from P. gingivalis-infected HCT116 cells. (a) Schematic showing the generation and mass spectrometry identification of large extracellular vesicles (lEVs) from P. gingivalis–infected HCT116 cells. P. gingivalis at a multiplicity of infection (MOI) of 100 was used for treatment. (b) Centrifugation protocol and workflow for lEV enrichment from P. gingivalis–infected HCT116 cells. (c) Representative particle size distribution of lEVs from P. gingivalis–infected or uninfected HCT116 cells determined by nanoparticle tracking analysis. Three biological replicates were analyzed for each group. (d) Transmission electron microscopy (TEM) image of lEVs isolated from P. gingivalis–infected or uninfected HCT116 cells. Scale bar = 100 nm. (e) Visualization of P. gingivalis infection in HCT116 cells. Bacteria were pre-stained with eFluor™ 670 (red), followed by infection of HCT116 cells. After 12 h, cell membranes were labeled with wheat germ agglutinin (WGA; green), and nuclei were counterstained with DAPI (blue).
